Immune Evasion Strategies of Glioblastoma

Overview of attention for article published in Frontiers in Surgery, March 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#9 of 3,480)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 23 news stories from 23 outlets.

CAMBRIDGE, Mass., Dec. 14, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage biopharmaceutical…

CAMBRIDGE, Mass., Dec. 14, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage biopharmaceutical…

CAMBRIDGE, Mass., Dec. 14, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage biopharmaceutical…

CAMBRIDGE, Mass., Dec. 14, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage biopharmaceutical…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 19 additional news stories.